Literature DB >> 21106643

Role of interleukin-18 in intrahepatic inflammatory cell recruitment in acute liver injury.

Kiminori Kimura1, Satoshi Sekiguchi, Seishu Hayashi, Yukiko Hayashi, Tsunekazu Hishima, Masahito Nagaki, Michinori Kohara.   

Abstract

Although the innate immune system has been demonstrated to play important roles as the first line of defense against various infections, little is known about the interactions between intrahepatic inflammatory cells and the cytokine network in the liver. Here, we examined the role of IL-18 in IHL recruitment in acute liver injury. C57BL/6 mice were injected with an αCD40 mAb, and their serum IL-18 levels were observed to increase, with subsequent recruitment of IHLs into the liver. NKT cells were involved in this liver injury, as the serum ALT levels were reduced in NKT KO mice through the suppression of macrophage and monocyte migration and cytokine production. In contrast, depletion of neutrophils exacerbated the liver injury associated with high levels of TNF-α and IL-18 and increased numbers of macrophages and monocytes. Treatment with a neutralizing antibody against IL-18 reduced the serum ALT levels and inflammatory cell accumulation in the liver. Finally, additional administration of rIL-18 with αCD40 injection caused severe liver injury with increased IFN-γ production by NK cells. In conclusion, these findings demonstrate that IL-18 modulates liver inflammation by the recruitment of inflammatory cells, including NKT cells, macrophages, monocytes, and neutrophils.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21106643     DOI: 10.1189/jlb.0710412

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  5 in total

1.  The interaction between IL-18 and IL-18 receptor limits the magnitude of protective immunity and enhances pathogenic responses following infection with intracellular bacteria.

Authors:  Purnima Ghose; Asim Q Ali; Rong Fang; Digna Forbes; Billy Ballard; Nahed Ismail
Journal:  J Immunol       Date:  2011-06-29       Impact factor: 5.422

2.  Effects of Chaihu-Shugan-San and Shen-Ling-Bai-Zhu-San on p38 MAPK Pathway in Kupffer Cells of Nonalcoholic Steatohepatitis.

Authors:  Qin-He Yang; Yong-Jian Xu; Yi-Zhen Liu; Yin-Ji Liang; Gao-Fei Feng; Yu-Pei Zhang; Hui-Jie Xing; Hai-Zhen Yan; Yuan-Yuan Li
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-25       Impact factor: 2.629

3.  Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice.

Authors:  Yosuke Osawa; Keisuke Oboki; Jun Imamura; Ekumi Kojika; Yukiko Hayashi; Tsunekazu Hishima; Toshiji Saibara; Futoshi Shibasaki; Michinori Kohara; Kiminori Kimura
Journal:  EBioMedicine       Date:  2015-10-08       Impact factor: 8.143

4.  Inherited IL-18BP deficiency in human fulminant viral hepatitis.

Authors:  Eleftherios Michailidis; Cecilia B Korol; Emmanuelle Jouanguy; Jean-Laurent Casanova; Serkan Belkaya; Mohammad Kabbani; Aurélie Cobat; Paul Bastard; Yoon Seung Lee; Nicholas Hernandez; Scott Drutman; Ype P de Jong; Eric Vivier; Julie Bruneau; Vivien Béziat; Bertrand Boisson; Lazaro Lorenzo-Diaz; Soraya Boucherit; Mylène Sebagh; Emmanuel Jacquemin; Jean-François Emile; Laurent Abel; Charles M Rice
Journal:  J Exp Med       Date:  2019-06-18       Impact factor: 14.307

5.  Screening differential circular RNA expression profiles reveals the regulatory role of circMARS in anti-tuberculosis drug-induced liver injury.

Authors:  Biao Li; Qi Ren; Yuhong Li; Shenqian Tian; Yingzhi Chong; Shufeng Sun; Fumin Feng
Journal:  J Cell Mol Med       Date:  2022-01-14       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.